Viewing Study NCT01203020


Ignite Creation Date: 2025-12-25 @ 4:13 AM
Ignite Modification Date: 2025-12-26 @ 3:12 AM
Study NCT ID: NCT01203020
Status: COMPLETED
Last Update Posted: 2023-07-13
First Post: 2010-09-13
Is NOT Gene Therapy: False
Has Adverse Events: True

Brief Title: Once Daily Targeted Intravenous (IV) Busulfex as Part of Reduced-toxicity Conditioning for Patients With Refractory Lymphomas Undergoing Allogeneic Transplantation
Sponsor: West Virginia University
Organization: